CA2197242A1

CA2197242A1 - Regulatable elimination of gene expression, gene product function and engineered host cells

Regulatable elimination of gene expression, gene product function and engineered host cells

Info

Publication number: CA2197242A1
Authority: CA; Canada
Prior art keywords: gene; cells; protein; ligand; domain
Prior art date: 1994-08-18
Legal status : Abandoned

Application number

CA002197242A

Other languages

English (en)

French (fr)

Inventor

Joan S. Brugge

Gerald R. Crabtree

Current Assignee

Ariad Gene Therapeutics Inc

Original Assignee

Individual

Priority date

1994-08-18

Filing date

1995-08-18

Publication date

1996-02-29

1994-08-18 Priority claimed from US08/292,597 external-priority patent/US5834266A/en

1995-08-18 Application filed by Individual filed Critical Individual

1996-02-29 Publication of CA2197242A1 publication Critical patent/CA2197242A1/en

Status Abandoned legal-status Critical Current

Links

108090000623 proteins and genes Proteins 0.000 title claims abstract description 465
230000014509 gene expression Effects 0.000 title claims abstract description 102
230000008030 elimination Effects 0.000 title claims abstract description 7
238000003379 elimination reaction Methods 0.000 title claims abstract description 7
239000003446 ligand Substances 0.000 claims description 193
102000004169 proteins and genes Human genes 0.000 claims description 135
230000000903 blocking effect Effects 0.000 claims description 87
230000009471 action Effects 0.000 claims description 40
230000004044 response Effects 0.000 claims description 23
108020001756 ligand binding domains Proteins 0.000 claims description 15
230000003213 activating effect Effects 0.000 claims description 9
108090000994 Catalytic RNA Proteins 0.000 claims description 8
102000053642 Catalytic RNA Human genes 0.000 claims description 8
230000000692 anti-sense effect Effects 0.000 claims description 8
108091092562 ribozyme Proteins 0.000 claims description 8
238000013518 transcription Methods 0.000 claims description 5
230000035897 transcription Effects 0.000 claims description 5
230000003472 neutralizing effect Effects 0.000 claims description 3
230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 3
108700026220 vif Genes Proteins 0.000 claims 1
238000000034 method Methods 0.000 abstract description 56
230000000694 effects Effects 0.000 abstract description 47
230000001105 regulatory effect Effects 0.000 abstract description 27
239000000463 material Substances 0.000 abstract description 16
238000001727 in vivo Methods 0.000 abstract description 9
230000004071 biological effect Effects 0.000 abstract description 5
238000000338 in vitro Methods 0.000 abstract description 3
238000012986 modification Methods 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 242
230000027455 binding Effects 0.000 description 136
235000018102 proteins Nutrition 0.000 description 124
102000005962 receptors Human genes 0.000 description 121
108020003175 receptors Proteins 0.000 description 121
108020001507 fusion proteins Proteins 0.000 description 119
102000037865 fusion proteins Human genes 0.000 description 119
239000000243 solution Substances 0.000 description 61
239000000047 product Substances 0.000 description 58
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 51
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 51
238000001994 activation Methods 0.000 description 51
230000004913 activation Effects 0.000 description 49
QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 48
108020004414 DNA Proteins 0.000 description 47
230000000977 initiatory effect Effects 0.000 description 42
101150036876 cre gene Proteins 0.000 description 40
229930105110 Cyclosporin A Natural products 0.000 description 39
108010036949 Cyclosporine Proteins 0.000 description 39
229960001265 ciclosporin Drugs 0.000 description 39
239000003153 chemical reaction reagent Substances 0.000 description 38
239000012528 membrane Substances 0.000 description 38
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
150000001413 amino acids Chemical group 0.000 description 32
239000012634 fragment Substances 0.000 description 32
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 29
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 28
102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 28
108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 28
235000001014 amino acid Nutrition 0.000 description 28
239000000539 dimer Substances 0.000 description 28
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
241001465754 Metazoa Species 0.000 description 25
230000004568 DNA-binding Effects 0.000 description 24
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 23
230000035772 mutation Effects 0.000 description 23
125000005647 linker group Chemical group 0.000 description 22
210000001519 tissue Anatomy 0.000 description 22
239000013612 plasmid Substances 0.000 description 21
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 20
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 20
108010068682 Cyclophilins Proteins 0.000 description 20
102000001493 Cyclophilins Human genes 0.000 description 20
230000015572 biosynthetic process Effects 0.000 description 20
230000001413 cellular effect Effects 0.000 description 20
239000003795 chemical substances by application Substances 0.000 description 20
230000001404 mediated effect Effects 0.000 description 20
239000012074 organic phase Substances 0.000 description 20
238000006243 chemical reaction Methods 0.000 description 19
230000006870 function Effects 0.000 description 19
238000003786 synthesis reaction Methods 0.000 description 19
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
230000006907 apoptotic process Effects 0.000 description 18
239000012230 colorless oil Substances 0.000 description 18
230000011664 signaling Effects 0.000 description 18
102000055209 human FKBP1A Human genes 0.000 description 17
229920006395 saturated elastomer Polymers 0.000 description 17
239000011734 sodium Substances 0.000 description 17
AHQFCPOIMVMDEZ-UNISNWAASA-N (e,2s,3r,4r)-3-hydroxy-4-methyl-2-(methylamino)oct-6-enoic acid Chemical compound CN[C@H](C(O)=O)[C@H](O)[C@H](C)C\C=C\C AHQFCPOIMVMDEZ-UNISNWAASA-N 0.000 description 16
101100446641 Homo sapiens FKBP1A gene Proteins 0.000 description 16
229910052757 nitrogen Inorganic materials 0.000 description 16
239000013598 vector Substances 0.000 description 16
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
108700008625 Reporter Genes Proteins 0.000 description 15
239000012071 phase Substances 0.000 description 15
229910052708 sodium Inorganic materials 0.000 description 15
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 14
241000699670 Mus sp. Species 0.000 description 14
108010076504 Protein Sorting Signals Proteins 0.000 description 14
125000004432 carbon atom Chemical group C* 0.000 description 14
239000002299 complementary DNA Substances 0.000 description 14
239000000203 mixture Substances 0.000 description 14
239000002904 solvent Substances 0.000 description 14
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
238000001415 gene therapy Methods 0.000 description 13
230000037361 pathway Effects 0.000 description 13
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 12
230000033228 biological regulation Effects 0.000 description 12
230000030833 cell death Effects 0.000 description 12
201000010099 disease Diseases 0.000 description 12
-1 i.e. Proteins 0.000 description 12
150000002500 ions Chemical class 0.000 description 12
239000003921 oil Substances 0.000 description 12
108700039691 Genetic Promoter Regions Proteins 0.000 description 11
108010002350 Interleukin-2 Proteins 0.000 description 11
102000000588 Interleukin-2 Human genes 0.000 description 11
210000001744 T-lymphocyte Anatomy 0.000 description 11
150000001875 compounds Chemical class 0.000 description 11
108010052621 fas Receptor Proteins 0.000 description 11
102000018823 fas Receptor Human genes 0.000 description 11
230000004927 fusion Effects 0.000 description 11
230000002068 genetic effect Effects 0.000 description 11
150000002632 lipids Chemical class 0.000 description 11
238000011282 treatment Methods 0.000 description 11
102100039556 Galectin-4 Human genes 0.000 description 10
101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 10
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 10
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 10
108091007433 antigens Proteins 0.000 description 10
ZDQSOHOQTUFQEM-NURRSENYSA-N ascomycin Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@@H](O)[C@H](OC)C1 ZDQSOHOQTUFQEM-NURRSENYSA-N 0.000 description 10
230000008859 change Effects 0.000 description 10
239000003814 drug Substances 0.000 description 10
239000003623 enhancer Substances 0.000 description 10
230000003834 intracellular effect Effects 0.000 description 10
230000014759 maintenance of location Effects 0.000 description 10
239000011541 reaction mixture Substances 0.000 description 10
239000007787 solid Substances 0.000 description 10
230000008685 targeting Effects 0.000 description 10
230000001225 therapeutic effect Effects 0.000 description 10
240000004808 Saccharomyces cerevisiae Species 0.000 description 9
239000000427 antigen Substances 0.000 description 9
102000036639 antigens Human genes 0.000 description 9
229940079593 drug Drugs 0.000 description 9
230000003993 interaction Effects 0.000 description 9
239000010410 layer Substances 0.000 description 9
102000004631 Calcineurin Human genes 0.000 description 8
108010042955 Calcineurin Proteins 0.000 description 8
102000014914 Carrier Proteins Human genes 0.000 description 8
108091028043 Nucleic acid sequence Proteins 0.000 description 8
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
239000008346 aqueous phase Substances 0.000 description 8
ZDQSOHOQTUFQEM-XCXYXIJFSA-N ascomycin Natural products CC[C@H]1C=C(C)C[C@@H](C)C[C@@H](OC)[C@H]2O[C@@](O)([C@@H](C)C[C@H]2OC)C(=O)C(=O)N3CCCC[C@@H]3C(=O)O[C@H]([C@H](C)[C@@H](O)CC1=O)C(=C[C@@H]4CC[C@@H](O)[C@H](C4)OC)C ZDQSOHOQTUFQEM-XCXYXIJFSA-N 0.000 description 8
108091008324 binding proteins Proteins 0.000 description 8
230000010354 integration Effects 0.000 description 8
239000000178 monomer Substances 0.000 description 8
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
238000003756 stirring Methods 0.000 description 8
229910001868 water Inorganic materials 0.000 description 8
108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 7
102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 7
108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 7
241000700605 Viruses Species 0.000 description 7
238000003556 assay Methods 0.000 description 7
230000001086 cytosolic effect Effects 0.000 description 7
239000012895 dilution Substances 0.000 description 7
238000010790 dilution Methods 0.000 description 7
239000013641 positive control Substances 0.000 description 7
230000002829 reductive effect Effects 0.000 description 7
238000012216 screening Methods 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
108010052285 Membrane Proteins Proteins 0.000 description 6
241001529936 Murinae Species 0.000 description 6
206010028980 Neoplasm Diseases 0.000 description 6
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
239000002253 acid Substances 0.000 description 6
125000000217 alkyl group Chemical group 0.000 description 6
150000001412 amines Chemical class 0.000 description 6
239000005557 antagonist Substances 0.000 description 6
108700010039 chimeric receptor Proteins 0.000 description 6
238000012217 deletion Methods 0.000 description 6
230000037430 deletion Effects 0.000 description 6
230000001419 dependent effect Effects 0.000 description 6
238000010586 diagram Methods 0.000 description 6
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
239000011521 glass Substances 0.000 description 6
230000012010 growth Effects 0.000 description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
108090000765 processed proteins & peptides Proteins 0.000 description 6
239000000126 substance Substances 0.000 description 6
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
238000011144 upstream manufacturing Methods 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
108020004705 Codon Proteins 0.000 description 5
241000124008 Mammalia Species 0.000 description 5
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
108091008874 T cell receptors Proteins 0.000 description 5
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 5
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 5
125000002947 alkylene group Chemical group 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
229910052799 carbon Inorganic materials 0.000 description 5
238000010367 cloning Methods 0.000 description 5
230000008878 coupling Effects 0.000 description 5
238000010168 coupling process Methods 0.000 description 5
238000005859 coupling reaction Methods 0.000 description 5
238000004132 cross linking Methods 0.000 description 5
125000004122 cyclic group Chemical group 0.000 description 5
230000034994 death Effects 0.000 description 5
239000012636 effector Substances 0.000 description 5
150000002148 esters Chemical class 0.000 description 5
239000000284 extract Substances 0.000 description 5
125000005842 heteroatom Chemical group 0.000 description 5
230000001939 inductive effect Effects 0.000 description 5
239000002609 medium Substances 0.000 description 5
230000001537 neural effect Effects 0.000 description 5
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 5
238000011160 research Methods 0.000 description 5
238000000926 separation method Methods 0.000 description 5
230000019491 signal transduction Effects 0.000 description 5
239000000741 silica gel Substances 0.000 description 5
229910002027 silica gel Inorganic materials 0.000 description 5
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 5
229960002930 sirolimus Drugs 0.000 description 5
241000894007 species Species 0.000 description 5
150000003431 steroids Chemical class 0.000 description 5
239000013638 trimer Substances 0.000 description 5
102000003298 tumor necrosis factor receptor Human genes 0.000 description 5
238000001086 yeast two-hybrid system Methods 0.000 description 5
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
239000004471 Glycine Substances 0.000 description 4
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
241000699660 Mus musculus Species 0.000 description 4
108091000080 Phosphotransferase Proteins 0.000 description 4
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
239000012190 activator Substances 0.000 description 4
230000006978 adaptation Effects 0.000 description 4
150000001299 aldehydes Chemical class 0.000 description 4
238000013459 approach Methods 0.000 description 4
210000003719 b-lymphocyte Anatomy 0.000 description 4
201000011510 cancer Diseases 0.000 description 4
238000013461 design Methods 0.000 description 4
150000004985 diamines Chemical class 0.000 description 4
210000002257 embryonic structure Anatomy 0.000 description 4
239000001963 growth medium Substances 0.000 description 4
239000001257 hydrogen Substances 0.000 description 4
229910052739 hydrogen Inorganic materials 0.000 description 4
125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
206010022000 influenza Diseases 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
230000002452 interceptive effect Effects 0.000 description 4
PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 4
PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 4
229910052760 oxygen Inorganic materials 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
150000003138 primary alcohols Chemical class 0.000 description 4
238000012545 processing Methods 0.000 description 4
238000004007 reversed phase HPLC Methods 0.000 description 4
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
102000005969 steroid hormone receptors Human genes 0.000 description 4
238000012360 testing method Methods 0.000 description 4
231100000331 toxic Toxicity 0.000 description 4
230000002588 toxic effect Effects 0.000 description 4
238000011830 transgenic mouse model Methods 0.000 description 4
230000001052 transient effect Effects 0.000 description 4
238000010396 two-hybrid screening Methods 0.000 description 4
OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
102000052510 DNA-Binding Proteins Human genes 0.000 description 3
101710096438 DNA-binding protein Proteins 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
101710103508 FK506-binding protein Proteins 0.000 description 3
101710104425 FK506-binding protein 2 Proteins 0.000 description 3
101710104423 FK506-binding protein 3 Proteins 0.000 description 3
101710104333 FK506-binding protein 4 Proteins 0.000 description 3
101710104342 FK506-binding protein 5 Proteins 0.000 description 3
101710149710 FKBP-type 16 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
101710121306 FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
101710180800 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA Proteins 0.000 description 3
108010051696 Growth Hormone Proteins 0.000 description 3
102000004877 Insulin Human genes 0.000 description 3
108090001061 Insulin Proteins 0.000 description 3
101710104030 Long-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
102000018697 Membrane Proteins Human genes 0.000 description 3
229930193140 Neomycin Natural products 0.000 description 3
101710114693 Outer membrane protein MIP Proteins 0.000 description 3
101710116692 Peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
101710111764 Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 description 3
101710111749 Peptidyl-prolyl cis-trans isomerase FKBP11 Proteins 0.000 description 3
101710111747 Peptidyl-prolyl cis-trans isomerase FKBP12 Proteins 0.000 description 3
101710111757 Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 description 3
101710111682 Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 description 3
101710111689 Peptidyl-prolyl cis-trans isomerase FKBP1B Proteins 0.000 description 3
101710147154 Peptidyl-prolyl cis-trans isomerase FKBP2 Proteins 0.000 description 3
101710147149 Peptidyl-prolyl cis-trans isomerase FKBP3 Proteins 0.000 description 3
101710147152 Peptidyl-prolyl cis-trans isomerase FKBP4 Proteins 0.000 description 3
101710147150 Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 description 3
101710147138 Peptidyl-prolyl cis-trans isomerase FKBP7 Proteins 0.000 description 3
102100036978 Peptidyl-prolyl cis-trans isomerase FKBP8 Human genes 0.000 description 3
101710147137 Peptidyl-prolyl cis-trans isomerase FKBP8 Proteins 0.000 description 3
101710147136 Peptidyl-prolyl cis-trans isomerase FKBP9 Proteins 0.000 description 3
101710174853 Peptidyl-prolyl cis-trans isomerase Mip Proteins 0.000 description 3
101710200991 Peptidyl-prolyl cis-trans isomerase, rhodopsin-specific isozyme Proteins 0.000 description 3
101710092145 Peptidyl-prolyl cis-trans isomerase-like 1 Proteins 0.000 description 3
101710092146 Peptidyl-prolyl cis-trans isomerase-like 2 Proteins 0.000 description 3
101710092148 Peptidyl-prolyl cis-trans isomerase-like 3 Proteins 0.000 description 3
101710092149 Peptidyl-prolyl cis-trans isomerase-like 4 Proteins 0.000 description 3
101710113444 Probable parvulin-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
101710090737 Probable peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
101710133309 Putative peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
101710124237 Short-type peptidyl-prolyl cis-trans isomerase Proteins 0.000 description 3
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
102100038803 Somatotropin Human genes 0.000 description 3
108010085012 Steroid Receptors Proteins 0.000 description 3
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
239000004473 Threonine Substances 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
208000007502 anemia Diseases 0.000 description 3
125000003710 aryl alkyl group Chemical group 0.000 description 3
125000003118 aryl group Chemical group 0.000 description 3
125000004429 atom Chemical group 0.000 description 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
239000000872 buffer Substances 0.000 description 3
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
230000033077 cellular process Effects 0.000 description 3
230000001276 controlling effect Effects 0.000 description 3
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
210000005220 cytoplasmic tail Anatomy 0.000 description 3
230000002950 deficient Effects 0.000 description 3
150000002170 ethers Chemical class 0.000 description 3
239000013604 expression vector Substances 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
239000011491 glass wool Substances 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
239000000122 growth hormone Substances 0.000 description 3
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
210000002865 immune cell Anatomy 0.000 description 3
230000028993 immune response Effects 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
229940125396 insulin Drugs 0.000 description 3
239000003550 marker Substances 0.000 description 3
102000006240 membrane receptors Human genes 0.000 description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
210000003098 myoblast Anatomy 0.000 description 3
230000017074 necrotic cell death Effects 0.000 description 3
229960004927 neomycin Drugs 0.000 description 3
239000012044 organic layer Substances 0.000 description 3
230000003647 oxidation Effects 0.000 description 3
238000007254 oxidation reaction Methods 0.000 description 3
239000001301 oxygen Substances 0.000 description 3
102000020233 phosphotransferase Human genes 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
230000008569 process Effects 0.000 description 3
230000009467 reduction Effects 0.000 description 3
229910052938 sodium sulfate Inorganic materials 0.000 description 3
235000011152 sodium sulphate Nutrition 0.000 description 3
210000000130 stem cell Anatomy 0.000 description 3
230000009261 transgenic effect Effects 0.000 description 3
230000032258 transport Effects 0.000 description 3
230000001960 triggered effect Effects 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
101150029062 15 gene Proteins 0.000 description 2
229960000549 4-dimethylaminophenol Drugs 0.000 description 2
102000006306 Antigen Receptors Human genes 0.000 description 2
108010083359 Antigen Receptors Proteins 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
108010031480 Artificial Receptors Proteins 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
101100245267 Caenorhabditis elegans pas-1 gene Proteins 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
206010053567 Coagulopathies Diseases 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
102000003746 Insulin Receptor Human genes 0.000 description 2
108010001127 Insulin Receptor Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
102000010789 Interleukin-2 Receptors Human genes 0.000 description 2
108010038453 Interleukin-2 Receptors Proteins 0.000 description 2
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
150000001204 N-oxides Chemical class 0.000 description 2
108010025020 Nerve Growth Factor Proteins 0.000 description 2
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
208000018737 Parkinson disease Diseases 0.000 description 2
108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 2
102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
101001020552 Rattus norvegicus LIM/homeobox protein Lhx1 Proteins 0.000 description 2
101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 2
102000004584 Somatomedin Receptors Human genes 0.000 description 2
108010017622 Somatomedin Receptors Proteins 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
102000004357 Transferases Human genes 0.000 description 2
108090000992 Transferases Proteins 0.000 description 2
108700025716 Tumor Suppressor Genes Proteins 0.000 description 2
102000044209 Tumor Suppressor Genes Human genes 0.000 description 2
229910052770 Uranium Inorganic materials 0.000 description 2
241000269370 Xenopus <genus> Species 0.000 description 2
108010046882 ZAP-70 Protein-Tyrosine Kinase Proteins 0.000 description 2
UCTLHLZWKJIXJI-LXIBVNSESA-N [(3s,8r,9s,10r,13s,14s)-17-chloro-16-formyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(Cl)=C(C=O)C[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 UCTLHLZWKJIXJI-LXIBVNSESA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
125000000732 arylene group Chemical group 0.000 description 2
210000003651 basophil Anatomy 0.000 description 2
239000002981 blocking agent Substances 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
238000009395 breeding Methods 0.000 description 2
230000001488 breeding effect Effects 0.000 description 2
125000001246 bromo group Chemical group Br* 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
150000004649 carbonic acid derivatives Chemical class 0.000 description 2
230000003915 cell function Effects 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000005754 cellular signaling Effects 0.000 description 2
230000035602 clotting Effects 0.000 description 2
239000012043 crude product Substances 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
150000002009 diols Chemical class 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
239000003480 eluent Substances 0.000 description 2
229940011871 estrogen Drugs 0.000 description 2
239000000262 estrogen Substances 0.000 description 2
230000002440 hepatic effect Effects 0.000 description 2
125000000623 heterocyclic group Chemical group 0.000 description 2
210000003630 histaminocyte Anatomy 0.000 description 2
230000003054 hormonal effect Effects 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
150000002466 imines Chemical class 0.000 description 2
230000001771 impaired effect Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000001965 increasing effect Effects 0.000 description 2
230000006698 induction Effects 0.000 description 2
108091008582 intracellular receptors Proteins 0.000 description 2
102000027411 intracellular receptors Human genes 0.000 description 2
238000005304 joining Methods 0.000 description 2
229910052744 lithium Inorganic materials 0.000 description 2
230000007774 longterm Effects 0.000 description 2
239000003120 macrolide antibiotic agent Substances 0.000 description 2
229940041033 macrolides Drugs 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
235000019341 magnesium sulphate Nutrition 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
210000000440 neutrophil Anatomy 0.000 description 2
239000012299 nitrogen atmosphere Substances 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
210000000287 oocyte Anatomy 0.000 description 2
210000003463 organelle Anatomy 0.000 description 2
229910000489 osmium tetroxide Inorganic materials 0.000 description 2
239000012285 osmium tetroxide Substances 0.000 description 2
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
238000002823 phage display Methods 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000006187 pill Substances 0.000 description 2
239000002243 precursor Substances 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
238000000159 protein binding assay Methods 0.000 description 2
229960000856 protein c Drugs 0.000 description 2
108020001580 protein domains Proteins 0.000 description 2
230000012743 protein tagging Effects 0.000 description 2
230000002685 pulmonary effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
108091008146 restriction endonucleases Proteins 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
230000001177 retroviral effect Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
230000028327 secretion Effects 0.000 description 2
108091006024 signal transducing proteins Proteins 0.000 description 2
102000034285 signal transducing proteins Human genes 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
235000010265 sodium sulphite Nutrition 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
230000004797 therapeutic response Effects 0.000 description 2
229940104230 thymidine Drugs 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
238000001890 transfection Methods 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
230000002792 vascular Effects 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
238000001262 western blot Methods 0.000 description 2
VXPULQMBPNGJOD-SECBINFHSA-N (2r)-2-amino-3-(4-hydroxyphenyl)-2-phosphonopropanoic acid Chemical compound OC(=O)[C@@](P(O)(O)=O)(N)CC1=CC=C(O)C=C1 VXPULQMBPNGJOD-SECBINFHSA-N 0.000 description 1
125000000923 (C1-C30) alkyl group Chemical group 0.000 description 1
AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical group CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
PIGCSKVALLVWKU-UHFFFAOYSA-N 2-Aminoacridone Chemical compound C1=CC=C2C(=O)C3=CC(N)=CC=C3NC2=C1 PIGCSKVALLVWKU-UHFFFAOYSA-N 0.000 description 1
IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
101150055869 25 gene Proteins 0.000 description 1
101150110188 30 gene Proteins 0.000 description 1
CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
108020005029 5' Flanking Region Proteins 0.000 description 1
CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
101150069942 ATR2 gene Proteins 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
241001136792 Alle Species 0.000 description 1
241000741629 Amiota cuii Species 0.000 description 1
240000000662 Anethum graveolens Species 0.000 description 1
101150022237 Appl gene Proteins 0.000 description 1
101100459266 Arabidopsis thaliana MYC3 gene Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
108091008875 B cell receptors Proteins 0.000 description 1
108010077805 Bacterial Proteins Proteins 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
241001598984 Bromius obscurus Species 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical group CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
210000003771 C cell Anatomy 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000251204 Chimaeridae Species 0.000 description 1
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
102100022641 Coagulation factor IX Human genes 0.000 description 1
108010072220 Cyclophilin A Proteins 0.000 description 1
108010072210 Cyclophilin C Proteins 0.000 description 1
108010036941 Cyclosporins Proteins 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
206010013883 Dwarfism Diseases 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
101150029707 ERBB2 gene Proteins 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
102100030013 Endoribonuclease Human genes 0.000 description 1
101710199605 Endoribonuclease Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000056372 ErbB-3 Receptor Human genes 0.000 description 1
102100030341 Ethanolaminephosphotransferase 1 Human genes 0.000 description 1
101710142265 Ethanolaminephosphotransferase 1 Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
108010012088 Fibrinogen Receptors Proteins 0.000 description 1
102100023374 Forkhead box protein M1 Human genes 0.000 description 1
102100029974 GTPase HRas Human genes 0.000 description 1
101710091881 GTPase HRas Proteins 0.000 description 1
208000015872 Gaucher disease Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
108010009202 Growth Factor Receptors Proteins 0.000 description 1
102000009465 Growth Factor Receptors Human genes 0.000 description 1
101150009006 HIS3 gene Proteins 0.000 description 1
102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
101000907578 Homo sapiens Forkhead box protein M1 Proteins 0.000 description 1
101001045751 Homo sapiens Hepatocyte nuclear factor 1-alpha Proteins 0.000 description 1
101001002657 Homo sapiens Interleukin-2 Proteins 0.000 description 1
101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
101000654298 Homo sapiens N-terminal kinase-like protein Proteins 0.000 description 1
101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
101000585484 Homo sapiens Signal transducer and activator of transcription 1-alpha/beta Proteins 0.000 description 1
101000637792 Homo sapiens Solute carrier family 35 member G5 Proteins 0.000 description 1
101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 1
101000607636 Homo sapiens Ubiquilin-3 Proteins 0.000 description 1
101150003028 Hprt1 gene Proteins 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
102000004553 Interleukin-11 Receptors Human genes 0.000 description 1
108010017521 Interleukin-11 Receptors Proteins 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
108010002335 Interleukin-9 Proteins 0.000 description 1
102000042838 JAK family Human genes 0.000 description 1
108091082332 JAK family Proteins 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
102000000853 LDL receptors Human genes 0.000 description 1
108010001831 LDL receptors Proteins 0.000 description 1
101710128836 Large T antigen Proteins 0.000 description 1
208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
102000004058 Leukemia inhibitory factor Human genes 0.000 description 1
108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
101150071228 Lifr gene Proteins 0.000 description 1
241000234435 Lilium Species 0.000 description 1
102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
108091054438 MHC class II family Proteins 0.000 description 1
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
108010058398 Macrophage Colony-Stimulating Factor Receptor Proteins 0.000 description 1
102100028198 Macrophage colony-stimulating factor 1 receptor Human genes 0.000 description 1
101710150918 Macrophage colony-stimulating factor 1 receptor Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
102000018897 Membrane Fusion Proteins Human genes 0.000 description 1
108010027796 Membrane Fusion Proteins Proteins 0.000 description 1
HGINADPHJQTSKN-UHFFFAOYSA-N Monoethyl malonic acid Chemical compound CCOC(=O)CC(O)=O HGINADPHJQTSKN-UHFFFAOYSA-N 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
101100445397 Mus musculus Ephb6 gene Proteins 0.000 description 1
101100335081 Mus musculus Flt3 gene Proteins 0.000 description 1
101100194350 Mus musculus Rere gene Proteins 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
102000006386 Myelin Proteins Human genes 0.000 description 1
108010083674 Myelin Proteins Proteins 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
108060008487 Myosin Proteins 0.000 description 1
125000003047 N-acetyl group Chemical group 0.000 description 1
AKCRVYNORCOYQT-YFKPBYRVSA-N N-methyl-L-valine Chemical class CN[C@@H](C(C)C)C(O)=O AKCRVYNORCOYQT-YFKPBYRVSA-N 0.000 description 1
102100031703 N-terminal kinase-like protein Human genes 0.000 description 1
239000007832 Na2SO4 Substances 0.000 description 1
102000015336 Nerve Growth Factor Human genes 0.000 description 1
102000007072 Nerve Growth Factors Human genes 0.000 description 1
101100329389 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cre-1 gene Proteins 0.000 description 1
102000017954 Nuclear factor of activated T cells (NFAT) Human genes 0.000 description 1
108050007058 Nuclear factor of activated T cells (NFAT) Proteins 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
102000004140 Oncostatin M Human genes 0.000 description 1
108010082522 Oncostatin M Receptors Proteins 0.000 description 1
102000016979 Other receptors Human genes 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
101150004094 PRO2 gene Proteins 0.000 description 1
241000282320 Panthera leo Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102100034539 Peptidyl-prolyl cis-trans isomerase A Human genes 0.000 description 1
102100024968 Peptidyl-prolyl cis-trans isomerase C Human genes 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
102100024819 Prolactin Human genes 0.000 description 1
108010057464 Prolactin Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102000001253 Protein Kinase Human genes 0.000 description 1
102100027584 Protein c-Fos Human genes 0.000 description 1
102000012515 Protein kinase domains Human genes 0.000 description 1
108050002122 Protein kinase domains Proteins 0.000 description 1
108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
240000001987 Pyrus communis Species 0.000 description 1
108010010469 Qa-SNARE Proteins Proteins 0.000 description 1
102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 1
101710141955 RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 1
241000700159 Rattus Species 0.000 description 1
102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 1
108091027981 Response element Proteins 0.000 description 1
101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
108010039491 Ricin Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 1
102000014400 SH2 domains Human genes 0.000 description 1
108050003452 SH2 domains Proteins 0.000 description 1
108060006706 SRC Proteins 0.000 description 1
102000001332 SRC Human genes 0.000 description 1
101100502845 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FPR1 gene Proteins 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
102100032019 Solute carrier family 35 member G5 Human genes 0.000 description 1
241000282887 Suidae Species 0.000 description 1
239000005864 Sulphur Substances 0.000 description 1
102000019197 Superoxide Dismutase Human genes 0.000 description 1
108010012715 Superoxide dismutase Proteins 0.000 description 1
102000050389 Syntaxin Human genes 0.000 description 1
208000000389 T-cell leukemia Diseases 0.000 description 1
208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
208000022292 Tay-Sachs disease Diseases 0.000 description 1
206010043391 Thalassaemia beta Diseases 0.000 description 1
241000532784 Thelia <leafhopper> Species 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
102000014384 Type C Phospholipases Human genes 0.000 description 1
108010079194 Type C Phospholipases Proteins 0.000 description 1
102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 1
102100021125 Tyrosine-protein kinase ZAP-70 Human genes 0.000 description 1
102100039935 Ubiquilin-3 Human genes 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
240000006365 Vitis vinifera Species 0.000 description 1
101100429091 Xiphophorus maculatus xmrk gene Proteins 0.000 description 1
GKXVJHDEWHKBFH-UHFFFAOYSA-N [2-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC=C1CN GKXVJHDEWHKBFH-UHFFFAOYSA-N 0.000 description 1
ISKQADXMHQSTHK-UHFFFAOYSA-N [4-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=C(CN)C=C1 ISKQADXMHQSTHK-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
125000002723 alicyclic group Chemical group 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
230000003281 allosteric effect Effects 0.000 description 1
125000003368 amide group Chemical group 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
230000003321 amplification Effects 0.000 description 1
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000003957 anion exchange resin Substances 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000000729 antidote Substances 0.000 description 1
229940075522 antidotes Drugs 0.000 description 1
230000034720 apoptotic signaling pathway Effects 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
239000012965 benzophenone Substances 0.000 description 1
PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
210000004958 brain cell Anatomy 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
OKTJSMMVPCPJKN-YPZZEJLDSA-N carbon-10 atom Chemical compound [10C] OKTJSMMVPCPJKN-YPZZEJLDSA-N 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000001886 ciliary effect Effects 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000019771 cognition Effects 0.000 description 1
239000002131 composite material Substances 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
125000004093 cyano group Chemical group *C#N 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
229930182912 cyclosporin Natural products 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
230000001461 cytolytic effect Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
230000009849 deactivation Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
230000002074 deregulated effect Effects 0.000 description 1
238000005828 desilylation reaction Methods 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
150000005690 diesters Chemical class 0.000 description 1
IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
BADXJIPKFRBFOT-UHFFFAOYSA-N dimedone Chemical compound CC1(C)CC(=O)CC(=O)C1 BADXJIPKFRBFOT-UHFFFAOYSA-N 0.000 description 1
239000007862 dimeric product Substances 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
150000002019 disulfides Chemical class 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
210000001163 endosome Anatomy 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
102000015694 estrogen receptors Human genes 0.000 description 1
108010038795 estrogen receptors Proteins 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
125000001153 fluoro group Chemical group F* 0.000 description 1
150000003948 formamides Chemical class 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
229960002963 ganciclovir Drugs 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000012252 genetic analysis Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
208000007345 glycogen storage disease Diseases 0.000 description 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
108090001052 hairpin ribozyme Proteins 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
150000002429 hydrazines Chemical class 0.000 description 1
150000004678 hydrides Chemical class 0.000 description 1
BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
239000005457 ice water Substances 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
150000002485 inorganic esters Chemical class 0.000 description 1
230000003914 insulin secretion Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 1
108040006856 interleukin-3 receptor activity proteins Proteins 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000004068 intracellular signaling Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
125000002346 iodo group Chemical group I* 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
208000017169 kidney disease Diseases 0.000 description 1
238000000021 kinase assay Methods 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
230000003902 lesion Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000004576 lipid-binding Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000006138 lithiation reaction Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
230000003387 muscular Effects 0.000 description 1
210000005012 myelin Anatomy 0.000 description 1
125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000007498 myristoylation Effects 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
MRWXACSTFXYYMV-FDDDBJFASA-N nebularine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC=C2N=C1 MRWXACSTFXYYMV-FDDDBJFASA-N 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
229940053128 nerve growth factor Drugs 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000006508 oncogene activation Effects 0.000 description 1
231100000590 oncogenic Toxicity 0.000 description 1
230000002246 oncogenic effect Effects 0.000 description 1
238000005580 one pot reaction Methods 0.000 description 1
239000013110 organic ligand Substances 0.000 description 1
238000005735 osmylation reaction Methods 0.000 description 1
210000002997 osteoclast Anatomy 0.000 description 1
238000007248 oxidative elimination reaction Methods 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
239000002245 particle Substances 0.000 description 1
RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
208000003068 pituitary dwarfism Diseases 0.000 description 1
230000003169 placental effect Effects 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
229940097325 prolactin Drugs 0.000 description 1
230000009682 proliferation pathway Effects 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
108060006633 protein kinase Proteins 0.000 description 1
239000002212 purine nucleoside Substances 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
102000016914 ras Proteins Human genes 0.000 description 1
108010014186 ras Proteins Proteins 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
239000012047 saturated solution Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
210000002955 secretory cell Anatomy 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000003584 silencer Effects 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
108020003113 steroid hormone receptors Proteins 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
239000000758 substrate Substances 0.000 description 1
PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical group CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
150000003568 thioethers Chemical class 0.000 description 1
125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
238000004448 titration Methods 0.000 description 1
238000006257 total synthesis reaction Methods 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
229960000281 trometamol Drugs 0.000 description 1
239000002753 trypsin inhibitor Substances 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
102000009310 vitamin D receptors Human genes 0.000 description 1
108050000156 vitamin D receptors Proteins 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
238000010792 warming Methods 0.000 description 1